Pharmaceutical Sterility Testing Market Size, Share, Growth Report 2030

Pharmaceutical Sterility Testing Market Size

The global Pharmaceutical Sterility Testing Market accrued earnings worth approximately 1.2(USD Billion) in 2020 and is predicted to gain revenue of about 2.3 (USD Billion) by 2028, is set to record a CAGR of nearly 11.9% over the period from 2021 to 2028. The report offers an assessment and analysis of the Pharmaceutical Sterility Testing Market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).

Pharmaceutical Sterility Testing Market: Outlook

Pharmaceutical sterility testing is needed at the time of sterilization validation methods and routine release testing. Apparently, sterility testing of pharmaceuticals is an examination of microorganisms. These tests are carried out under a clean environment through membrane filtration procedures by use of an isolator. The rise in the number of new drug launches aided by rising in research activities will mark a new era in the growth of the pharmaceutical sterility testing industry over the forecast timespan. Technological breakthroughs witnessed in sterility testing procedures have resulted in a reduction of procedural time and human intervention, thereby creating lucrative avenues for the pharmaceutical sterility testing industry.

Request Free Sample

Pharmaceutical Sterility Testing Market: Growth Factors

The rise in the allocation of funds for the healthcare industry and massive investment in research activities for improving the quality of pharma products will prop up the size of the pharmaceutical sterility testing market. Growing approvals of new product launches by regulatory authorities such as the FDA in countries like the U.S. will enlarge scope of the pharmaceutical sterility testing industry. Large-scale use of statistical techniques for ensuring a high percentage of efficiency in sterility testing of drugs will boost the growth of the pharmaceutical sterility testing market. With the rise in outsourcing activities across the globe, firms in the pharmaceutical business are outsourcing sterility testing for facilitating cost reduction. Furthermore, the easy availability of a large number of contract labs offering high-quality sterility testing of pharmaceuticals will drive market trends.

Report Scope:

Moreover, sterility testing has massive applications in the pharmaceutical sector ranging from medicine production to cell banks as well as various drug offerings along with testing and preparing of various medicines to be sterilized. All these aforementioned factors are likely to drive the expansion of the pharmaceutical sterility testing industry. In addition to this, the necessity of sterile testing of biological parenteral preparations for human use will further drive the industry landscape.

Pharmaceutical Sterility Testing Market: Regional Landscape

North America To Make Notable Contributions Towards Overall Market Size By 2028

The growth of the pharmaceutical sterility testing market in North America over the forecast timeline is due to the humungous presence of giant players in countries such as the U.S. and Canada. Furthermore, strict regulations regarding the sterilization of pharma products in these countries will promulgate the scope of growth of the pharmaceutical sterility testing industry in North America. With a large number of firms focusing on acquiring local players for business expansion in the region, the market for pharmaceutical sterility testing in North America is projected to expand leaps & bounds in forthcoming years.

Key players contributing to market size and profiled in the study include Nelson Laboratories, SGS SA, Toxikon, Inc., Boston Analytical, Pace Analytical Services, LLC, and Charles River Laboratories International, Inc.

The global Pharmaceutical Sterility Testing Market is segmented as follows:

By Type

• In-house
• Outsourcing

By Test Type

• Sterility Testing
• Bioburden Testing
• Bacterial Endotoxin Testing

By Sample

• Sterile Drugs
• Medical Devices
• Biologics & Therapeutics

By End-Use

• Compounding Pharmacies
• Medical Devices Companies
• Pharmaceutical Companies

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa